Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9.

The CRISPR-Cas9 system has revolutionized our ability to precisely modify the genome and has led to gene editing in clinical applications. Comprehensive analysis of gene editing products at the targeted cut-site has revealed a complex spectrum of outcomes. ON-target genotoxicity is underestimated with standard PCR-based methods and necessitates appropriate and more sensitive detection methods.

The Effects of Conscious Movement Processing on the Neuromuscular Control of Posture.

Maintaining balance is thought to primarily occur sub-consciously. Occasionally, however, individuals will direct conscious attention towards balance, e.g.

A Case Study on the Management of the Behavioral Sequelae of Traumatic Brain Injury.

We present the case of a 46-year-old male with a history of post-traumatic stress disorder and opioid use disorder who sustained a severe traumatic brain injury secondary to motor vehicle accident and was brought to the attention of our psychiatry consultation-liaison team owing to significant physical and verbal aggression. This article will detail the specific behavioral and pharmacological management for this patient's symptoms. Additionally, experts in the field of consultation and liaison psychiatry will provide guidance based on their experience and a review of the available literature.

ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected.

CRISPR-Cas9 is a highly promising technology for clinical development. However, this powerful tool can induce adverse genomic events. The off-target genotoxicity is well described, predictable, detectable, and resolved by the use of new generations of Cas9 nucleases with high fidelity.

CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells.

CRISPR-Cas9 is a promising technology for gene therapy. However, the ON-target genotoxicity of CRISPR-Cas9 nuclease due to DNA double-strand breaks has received little attention and is probably underestimated. Here we report that genome editing targeting globin genes induces megabase-scale losses of heterozygosity (LOH) from the globin CRISPR-Cas9 cut-site to the telomere (5.